Answers are grounded in this paper and cite their sources.
There are few agents used in soft-tissue sarcoma treatment. We compared the efficacy of therapies, aiming to identify the best therapy sequence, and reveal the factors affecting the risk of progression or death.
No takes yet. Share an insight, caveat, or question.
Burcu Caner (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: